As cellular therapies are advancing through clinical development and getting closer to market, close collaborations between stem cell biologists, clinical cell processing technologists, and bioengineers will be required for effective commercialization of this new class of drugs. New cell production strategies and technologies will be needed to supply sufficient quantities of cells, of pre-defined quality and biological functionality, and at reasonable costs as these new products come to market. Just as protein therapeutics went through a technology transformation during the 1990’s, cell therapy bioprocessing technologies will go through a similar standardization and scalability evolution over the next 5-15 years. This Webinar will outline many of the challenges and opportunities that lie before the Cell Therapy industry as it transforms from a niche market industry to blockbuster drug status, with a real-world example of a cell therapy drug in mid-stage clinical development.
Please join us as this new industry evolves, and as the technical discipline of Cell Therapy Bioprocesing is emerging.
Would you like to access this content?
No problem. You just have to complete the following steps.
You have completed 0 of 2 steps.
You must be logged in to view this content. Log in now.
You must purchase this webinar using one of the options below.
If you already purchased this content recently, please click here to refresh the system's record of ownerships.
|List Price||$99.00 Buy now|
|AIChE Members||$69.00 Buy now|
|AIChE Undergraduate Student Members||Free Free access|
|AIChE Graduate Student Members||$69.00 Buy now|
|SBE Members||Free Free access|